z-logo
open-access-imgOpen Access
Diagnostic value of gadolinium-enhanced dynamic MR imaging for parotid gland tumors
Author(s) -
Hazem Mohamed El Shahat,
Hadeer Safwat Fahmy,
Ghada K. Gouhar
Publication year - 2013
Publication title -
the egyptian journal of radiology and nuclear medicine /the egyptian journal of radiology and nuclear medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.19
H-Index - 13
eISSN - 2090-4762
pISSN - 0378-603X
DOI - 10.1016/j.ejrnm.2013.02.007
Subject(s) - gadolinium , medicine , washout , parotid gland , magnetic resonance imaging , parotidectomy , pleomorphic adenoma , nuclear medicine , radiology , dynamic imaging , pathology , salivary gland , chemistry , image processing , digital image processing , artificial intelligence , computer science , image (mathematics) , organic chemistry
AbstractObjectiveThis study aimed to evaluate the value of gadolinium-enhanced dynamic MR imaging for differentiating benign and malignant parotid gland tumors, and for characterizing the various histological types.Patients and methodsNon-enhanced T1-weighted (T1-W), fat-suppressed T2-weighted (T2-W), and gadolinium-enhanced fat-suppressed dynamic T1-weighted images were obtained preoperatively in 27 patients (28 parotid gland tumors), by using a 1.5 or 3 T MR imaging unit (GE, Signa Exite). The tumor margins and the enhancement curve patterns on dynamic MR imaging were analyzed. All patients underwent a parotidectomy with histopathologic analysis.ResultsPleomorphic adenomas depict a gradual enhancement pattern. Warthin’s tumors depict an early peak of enhancement and a high washout pattern. Malignant tumors depict an early peak of enhancement and a low washout pattern.ConclusionGadolinium-enhanced dynamic MR imaging improved the performance of MR imaging in differentiating benign from malignant parotid gland tumors and characterizing the different histological types of benign tumors

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here